Processa Pharmaceuticals, Inc. Interest Payable, Current
Processa Pharmaceuticals, Inc. (PCSA) had Interest Payable, Current of $1.31 thousand as of 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2022-03-30
- 2021-03-31: Interest Payable, Current $1.31K.
- 2020-12-31: Interest Payable, Current $950.00.
- 2020-09-30: Interest Payable, Current $89.70K.
- 2020-06-30: Interest Payable, Current $58.48K.
| Period end | Interest Payable, Current | Interest Payable, Current as first filed |
|---|---|---|
| 2021-03-31 | $1.31K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $950.00 10-K · filed 2022-03-30 | |
| 2020-09-30 | $89.70K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $58.48K 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $38.00K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $21.90K 10-K · filed 2021-03-25 | |
| 2019-06-30 | $28.93K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $24.94K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $20.34K 10-K · filed 2020-03-06 | |
| 2018-09-30 | $15.74K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $11.14K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $87.29K 10-Q · filed 2018-05-21 | |
| 2017-12-31 | $35.69K 10-K/A · filed 2019-04-08 | |
| 2017-06-30 | $566.53K 10-Q · filed 2017-10-04 | |
| 2017-03-31 | $503.12K 10-Q · filed 2017-10-04 | |
| 2016-12-31 | $441.17K 10-Q · filed 2017-11-20 | |
| 2016-09-30 | $377.85K 10-Q · filed 2017-09-08 | |
| 2016-06-30 | $314.53K 10-Q · filed 2017-08-30 | |
| 2016-03-31 | $212.51K 10-Q · filed 2017-08-07 | |
| 2015-12-31 | $161.61K 10-K · filed 2017-09-25 | |
| 2015-09-30 | $104.15K 10-Q · filed 2015-12-01 | |
| 2015-06-30 | $51.16K 10-Q · filed 2015-08-19 | |
| 2015-03-31 | $28.42K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $7.82K 10-K · filed 2017-06-19 | $19.54K 10-K · filed 2015-04-14 |
| 2013-12-31 | $1.81K 10-K · filed 2015-04-14 | |
| 2013-09-30 | $2.63K 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $2.63K 10-Q/A · filed 2013-09-06 | |
| 2012-12-31 | $2.63K 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |